Canadian Sec - Delayed Quote CAD
Xebra Brands Ltd. (XBRA.CN)
0.0800
0.0000
(0.00%)
At close: April 25 at 9:30:00 AM EDT
Breakdown
TTM
2/29/2024
2/28/2023
2/28/2022
2/28/2021
Total Revenue
0.0010
106.8550
158.9490
--
--
Cost of Revenue
309.8340
415.2770
174.9780
--
--
Gross Profit
-309.8330
-308.4220
-16.0290
--
--
Operating Expense
1,068.8170
1,246.1160
2,913.3090
3,447.6210
1,830.3800
Operating Income
-1,378.6500
-1,554.5380
-2,929.3380
-3,447.6210
-1,830.3800
Net Non Operating Interest Income Expense
--
--
--
-6.5360
-8.1980
Other Income Expense
-586.8120
-403.6200
-1,178.9220
-1,082.1680
-42.8000
Pretax Income
-1,965.4620
-1,958.1580
-4,108.2600
-4,536.3250
-1,881.3780
Net Income Common Stockholders
-1,965.0510
-1,957.3800
-4,024.2700
-6,142.6580
-1,860.0480
Diluted NI Available to Com Stockholders
-1,965.0510
-1,957.3800
-4,024.2700
-6,142.6580
-1,860.0480
Basic EPS
-0.03
-0.04
-0.10
-0.25
-0.09
Diluted EPS
-0.03
-0.04
-0.10
-0.25
-0.09
Basic Average Shares
68,308.7940
54,235.8560
38,994.1530
24,308.0600
20,730.9070
Diluted Average Shares
68,308.7940
54,235.8560
38,994.1530
24,308.0600
20,730.9070
Total Expenses
1,378.6510
1,661.3930
3,088.2870
3,447.6210
1,830.3800
Net Income from Continuing & Discontinued Operation
-1,965.0510
-1,957.3800
-4,024.2700
-6,142.6580
-1,860.0480
Normalized Income
-1,322.2000
-1,510.1590
-2,968.7510
-3,373.1210
-1,790.2920
Interest Income
--
--
--
1.4220
0.0040
Interest Expense
--
--
--
6.5360
8.2020
Net Interest Income
--
--
--
-6.5360
-8.1980
EBIT
-1,378.6500
-1,554.5380
-2,929.3380
-4,529.7890
-1,873.1760
EBITDA
-1,363.7630
-1,494.9960
-2,820.9010
-3,926.4150
-1,322.8680
Reconciled Cost of Revenue
309.5710
415.2770
174.9780
--
--
Reconciled Depreciation
14.8870
59.5420
108.4370
603.3740
550.3080
Net Income from Continuing Operation Net Minority Interest
-1,965.0510
-1,957.3800
-4,008.2340
-4,417.9660
-1,860.0480
Total Unusual Items Excluding Goodwill
-642.8510
-447.2210
-1,039.4830
-1,044.8450
-69.7560
Total Unusual Items
-642.8510
-447.2210
-1,039.4830
-1,044.8450
-69.7560
Normalized EBITDA
-720.9120
-1,047.7750
-1,781.4180
-2,881.5700
-1,253.1120
2/28/2021 - 10/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RVVQF RavenQuest BioMed Inc.
0.0000
0.00%
HIGH.DU Cantourage Group SE
4.8600
+1.04%
WRHLF Love Hemp Group Plc
0.0001
0.00%
CNTR.CN CENTR Brands Corp.
0.0500
0.00%
SBX.DE SynBiotic SE
3.1100
+1.97%
LOWLF Lowell Farms Inc.
0.0130
0.00%
HCANF Halo Collective Inc.
0.0001
0.00%
NLVVF New Leaf Ventures Inc
0.0040
0.00%
MUSH.V Mercanto Holdings Inc.
0.0550
0.00%
FH.NE Filament Health Corp.
0.0300
-14.29%